# Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

> **NCT05172063** · — · UNKNOWN · sponsor: **Children's Cancer Hospital Egypt 57357** · enrollment: 30 (estimated)

## Conditions studied

- Children With Cancer
- SARS-CoV-2 Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05172063
- **Lead sponsor:** Children's Cancer Hospital Egypt 57357
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05172063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05172063, "Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05172063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*